Archived: Summary of NACI statement of June 9, 2023: Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series

Resumen documental de ASEM

Official National Advisory Committee on Immunization document (2023) on “Archived: Summary of NACI statement of June 9, 2023: Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series”. Summary of NACI guidance on the use of Omicron-containing COVID-19 vaccines including methods, recommendations and more.

Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.